A Novel Interaction between Thyroid Hormones and 1,25(OH)2D3 in Osteoclast Formation

This publication has 32 references indexed in Scilit:

• Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
  Endocrine Reviews, 1999
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
  Proceedings of the National Academy of Sciences, 1999
• A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and Function
  Biochemical and Biophysical Research Communications, 1999
• Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
  Cell, 1998
• Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
  Cell, 1997
• Thyroid hormones and bone
  Journal of Endocrinology, 1993
• Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro
  Biochemical and Biophysical Research Communications, 1991
• Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.
  The Journal of Experimental Medicine, 1991
• SPINAL BONE MINERAL CONTENT IN MYXOEDEMA AND THYROTOXICOSIS. EFFECTS OF THYROID HORMONE(S) AND ANTITHYROID TREATMENT
  Clinical Endocrinology, 1983
• A Tetracycline‐Based Histomorphometric Evaluation of Bone Resorption and Bone Turnover in Hyperthyroidism and Hyperparathyroidism
  Acta Medica Scandinavica, 1978